Coq10 Endothelial Function Randomized Trial Evidence Table

Structured evidence table for Coq10 Endothelial Function Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Coq10 Endothelial Function Randomized TrialDespite major advancements in pharmacotherapies and interventional cardiology, substantial residual risk persists among patients with established disease ().3Wu Xun (2026)Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
Coq10 Endothelial Function Randomized TrialAdditionally, many nutraceuticals are perceived to possess favorable safety and tolerability profiles compared to conventional medications, making them attractive for long-term risk reduction ().3Wu Xun (2026)Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
Coq10 Endothelial Function Randomized TrialBanach et al., 2018 Cicero et al., 2017 Sesso et al., 2008 However, the field is marked by heterogeneous and sometimes contradictory evidence.3Wu Xun (2026)Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
Coq10 Endothelial Function Randomized TrialRoth et al., 2020 Ganda et al., 2018 Visseren et al., 2021 Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for nearly one-third of global deaths each year ().3Wu Xun (2026)Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
Coq10 Endothelial Function Randomized TrialIrreversible ocular diseases that result in blindness present a significant challenge in contemporary medicine, as no fully effective cure exists; current treatments primarily aim to decelerate disease progression, manage symptoms, and preserve residual vision.4Wiciński M (2026)Review of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa.
Coq10 Endothelial Function Randomized TrialCoenzyme Q10 (CoQ10), a natural antioxidant produced by the human body, has strong anti-inflammatory properties, reduces oxidative stress, and improves mitochondrial function.4Wiciński M (2026)Review of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa.
Coq10 Endothelial Function Randomized TrialWith age, endogenously produced CoQ10 levels decline, contributing to the development of chronic diseases, including eye disorders.4Wiciński M (2026)Review of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa.
topicCoq10 Endothelial Function Randomized Trial
claimDespite major advancements in pharmacotherapies and interventional cardiology, substantial residual risk persists among patients with established disease ().
evidence level3
citationWu Xun (2026)
sourceAdvances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
topicCoq10 Endothelial Function Randomized Trial
claimAdditionally, many nutraceuticals are perceived to possess favorable safety and tolerability profiles compared to conventional medications, making them attractive for long-term risk reduction ().
evidence level3
citationWu Xun (2026)
sourceAdvances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
topicCoq10 Endothelial Function Randomized Trial
claimBanach et al., 2018 Cicero et al., 2017 Sesso et al., 2008 However, the field is marked by heterogeneous and sometimes contradictory evidence.
evidence level3
citationWu Xun (2026)
sourceAdvances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
topicCoq10 Endothelial Function Randomized Trial
claimRoth et al., 2020 Ganda et al., 2018 Visseren et al., 2021 Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for nearly one-third of global deaths each year ().
evidence level3
citationWu Xun (2026)
sourceAdvances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
topicCoq10 Endothelial Function Randomized Trial
claimIrreversible ocular diseases that result in blindness present a significant challenge in contemporary medicine, as no fully effective cure exists; current treatments primarily aim to decelerate disease progression, manage symptoms, and preserve residual vision.
evidence level4
citationWiciński M (2026)
sourceReview of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa.
topicCoq10 Endothelial Function Randomized Trial
claimCoenzyme Q10 (CoQ10), a natural antioxidant produced by the human body, has strong anti-inflammatory properties, reduces oxidative stress, and improves mitochondrial function.
evidence level4
citationWiciński M (2026)
sourceReview of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa.
topicCoq10 Endothelial Function Randomized Trial
claimWith age, endogenously produced CoQ10 levels decline, contributing to the development of chronic diseases, including eye disorders.
evidence level4
citationWiciński M (2026)
sourceReview of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa.

Source documents

  1. Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
  2. Review of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa.